RIVASTIGMINE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | RIVASTIGMINE |
| DrugBank ID | DB00989 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 29 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| adult-onset myasthenia gravis | TxGNN Knowledge Graph | L5 |
| myasthenia gravis | TxGNN Knowledge Graph | L5 |
| neuromuscular junction disease | TxGNN Knowledge Graph | L5 |
| obsolete hodgkin's granuloma | TxGNN Knowledge Graph | L5 |
| mantle cell lymphoma | TxGNN Knowledge Graph | L5 |
| hodgkins lymphoma | TxGNN Knowledge Graph | L5 |
| polycythemia (disease) | TxGNN Knowledge Graph | L5 |
| primary cutaneous t-cell non-hodgkin lymphoma | TxGNN Knowledge Graph | L5 |
| lymphosarcoma | TxGNN Knowledge Graph | L5 |
| plasmacytoma | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11